Corzo Kathryn Penkus 4
4 · Marker Therapeutics, Inc. · Filed Nov 4, 2025
Insider Transaction Report
Form 4
Corzo Kathryn Penkus
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-10-31+147,611→ 147,611 totalExercise: $0.99Exp: 2035-10-31→ Common Stock (147,611 underlying)
Footnotes (1)
- [F1]Represents options granted under the Company's 2020 Omnibus Stock Ownership Plan. The shares vest equally over thirty six (36) monthly installments, subject to the Reporting Person's continued service as a director. The option exercise price is the closing price on the date of the grant, October 31, 2025.